Key achievements included positive Phase 3 ASPEN data for brensocatib in bronchiectasis, record-breaking ARIKAYCE revenues, and advancements in other pipeline programs such as TPIP and ARIKAYCE's ...
A few baseline characteristics can predict the need for recurrent endoscopic sinus surgery among patients with CRSwNP.
KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present for a minimum of 3 months.[1][1] Its true prevalence is difficult to ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
The following is a summary of “Unveiling the Prevalence and Impact of Silent Rhinovirus Infection in Chronic Rhinosinusitis with Nasal Polyps,” published in the January 2025 issue of Annals of Allergy ...
Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...
Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections. Learn more!
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...
Nasal polyps are benign mucosal protrusions that can, in severe cases, block the nostrils entirely. Nasal polyps often develop in conjunction with a prolonged sinus infection, leading to chronic ...
Hosted on MSN18d
GSK's depemokimab gets EMA nod for asthma and nasal polypsSimilarly, the ANCHOR-1 and ANCHOR-2 studies found that depemokimab effectively reduced the size and obstruction of nasal polyps compared to placebo. Kaivan Khavandi, SVP, Global Head of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results